Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy
Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells with Markers of the Epithelial–Mesenchymal Transition, Due to Loss of NAPRT
Gastroenterology, Published online May 15, 2018 | DOI: https://doi.org/10.1053/j.gastro.2018.05.024
![[Merck] 생명과학 연구장비 설문조사 및 KOREA LAB 전시회 부스 방문 이벤트](/app/board/attach/image/1351293_1774355041000.do?)
![[Azure] qPCR 장비·Microplate Reader·Western Blot 제품 라인업](/app/board/attach/image/1349846_1773213922000.do?)
